Scott Rybak
About Scott Rybak
Scott Rybak serves as the Senior Vice President of Business Development at CoverMyMeds, where he has contributed to the company's growth for over a decade. He has extensive experience in forming strategic partnerships within the healthcare and technology sectors.
Work at CoverMyMeds
Scott Rybak serves as the Senior Vice President of Business Development at CoverMyMeds. He has held this position since 2012, contributing to the company's growth and expansion strategies for over a decade. His role involves leading business development initiatives and forming strategic partnerships that enhance the company's market presence. Rybak's efforts have been pivotal in establishing relationships with key stakeholders in the healthcare sector, including Pharmacy Benefit Managers (PBMs), Health Plans, and Electronic Medical Record (EMR) vendors.
Education and Expertise
Scott Rybak studied at Towson University from 1983 to 1987, where he developed foundational knowledge that supports his career in business development. With over 30 years of experience in sales and business development roles, he has cultivated expertise across the healthcare and technology sectors. His extensive background includes forming strategic partnerships that drive business growth and improve healthcare delivery.
Background
Before joining CoverMyMeds, Scott Rybak worked at EDS as Vice President of Sales and Business Development from 1988 to 1994. His six-year tenure at EDS provided him with significant experience in sales strategies and business development within the technology sector. This background laid the groundwork for his subsequent roles in the healthcare industry, where he has focused on building partnerships and expanding business opportunities.
Achievements
During his time at CoverMyMeds, Scott Rybak has been instrumental in expanding the company's business development initiatives. His strategic approach has led to the establishment of crucial partnerships with various stakeholders in the healthcare ecosystem. Rybak's contributions have supported the company's mission to improve medication access and adherence, showcasing his commitment to enhancing healthcare outcomes.